{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:33:59Z","timestamp":1759530839515},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T00:00:00Z","timestamp":1284595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Comparative Oncology"],"published-print":{"date-parts":[[2011,6]]},"abstract":"<jats:p>5\u2010Lipoxygenase (5\u2010LO) is overexpressed in human prostate carcinomas (PCs), and its inhibition decreases proliferation and induces apoptosis in prostate cancer cell lines. We hypothesized that 5\u2010LO would be overexpressed in canine PC compared with benign prostate tissue and may be important in the pathogenesis of the disease. Immunoblot analysis of canine PC and benign prostatic hyperplasia (BPH) tissues demonstrated 5\u2010LO expression in both. 5\u2010LO immunohistochemical staining was not significantly different within the stromal or epithelial components of canine primary PC, BPH or suppurative prostatitis, suggesting that differential expression of this enzyme does not occur in these conditions. The percentage of tumour cells expressing 5\u2010LO was significantly lower in metastatic PC lesions compared with primary PC (<jats:italic>P<\/jats:italic> &lt; 0.0001). This decreased expression may indicate down\u2010regulation or altered expression of the enzyme with progression of canine PC to a metastatic phenotype.<\/jats:p>","DOI":"10.1111\/j.1476-5829.2010.00245.x","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T06:26:24Z","timestamp":1284618384000},"page":"149-157","source":"Crossref","is-referenced-by-count":7,"title":["5\u2010Lipoxygenase expression in benign and malignant canine prostate tissues<sup>*<\/sup>"],"prefix":"10.1111","volume":"9","author":[{"given":"L. A.","family":"Goodman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. L.","family":"Jarrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M.","family":"Krunkosky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. C.","family":"Budsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. C.","family":"Northrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. F.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. E.","family":"LeRoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,9,16]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1996.tb05875.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(89)90132-2"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91611-5"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.7.4440"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.242716099"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.14.10.1464"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038190"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer.","volume":"10","author":"Wang D","journal-title":"Nature Reviews Cancer"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i39.6355"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4631"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-3278(03)00110-8"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64198-3"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000080296.54262.c8"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgi026"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1684"},{"key":"e_1_2_6_17_2","first-page":"1109","article-title":"Increased expression of 5\u2010lipoxygenase is common in clear cell renal cell carcinoma.","volume":"22","author":"Faronato M","year":"2007","journal-title":"Histology and Histopathology"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000195096.43258.94"},{"key":"e_1_2_6_19_2","first-page":"821","article-title":"Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.","volume":"24","author":"Matsuyama M","year":"2004","journal-title":"International Journal of Oncology"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F"},{"key":"e_1_2_6_21_2","first-page":"99","article-title":"Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.","volume":"18","author":"Matsuyama M","year":"2007","journal-title":"Oncology Reports"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2008.05.001"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)02014-4"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0150com"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.22.13182"},{"key":"e_1_2_6_26_2","first-page":"2393","article-title":"Anticancer effects of licofelone (ML\u20103000) in prostate cancer cells.","volume":"27","author":"Narayanan NK","year":"2007","journal-title":"Anticancer Research"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.77"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20720"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2008.07.012"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0045(20001001)45:2<173::AID-PROS12>3.0.CO;2-R"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.16.1398"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1354\/vp.40-2-207"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2007.tb03021.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/174657"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2133253100"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.37.21652"}],"container-title":["Veterinary and Comparative Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5829.2010.00245.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5829.2010.00245.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:53:25Z","timestamp":1698731605000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5829.2010.00245.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,16]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["10.1111\/j.1476-5829.2010.00245.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5829.2010.00245.x","archive":["Portico"],"relation":{},"ISSN":["1476-5810","1476-5829"],"issn-type":[{"value":"1476-5810","type":"print"},{"value":"1476-5829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,16]]}}}